{"id":7312,"date":"2025-11-12T12:33:16","date_gmt":"2025-11-12T12:33:16","guid":{"rendered":"https:\/\/oncopeptides.com.haus.se\/newsroom\/news\/nkengage-grant-projektet-slutfort\/"},"modified":"2026-04-10T16:55:30","modified_gmt":"2026-04-10T16:55:30","slug":"nkengage-grant-projektet-slutfort","status":"publish","type":"news","link":"https:\/\/oncopeptides.com.haus.se\/sv\/nyheter\/nkengage-grant-projektet-slutfort\/","title":{"rendered":"NKEngage Grant-projektet slutf\u00f6rt"},"content":{"rendered":"<p class=\"preamble\">NKEngage-projektet, finansierat genom Eurostars-programmet (Vinnova\/Eureka), har framg\u00e5ngsrikt avslutats efter att ha uppn\u00e5tt sina forskningsm\u00e5l. Konsortiet levererade prekliniska bevis p\u00e5 konceptet f\u00f6r en ny affibody-polypeptid utformad f\u00f6r immunterapi med naturliga m\u00f6rdarceller (NK-celler) riktad mot multipelt myelom (MM) \u2014 en aggressiv och f\u00f6r n\u00e4rvarande obotlig blodcancer.<\/p>\n<p><strong>Viktiga resultat:<\/strong><\/p>\n<ul>\n<li>Visade effekt i att aktivera NK-celler mot prim\u00e4ra MM-prover, \u00f6vervinna h\u00e4mmande mekanismer och fr\u00e4mja seriem\u00e4ssig tum\u00f6rcellsd\u00f6d.<\/li>\n<li>F\u00f6rb\u00e4ttrade v\u00e5ra processer f\u00f6r produktion och karakterisering av v\u00e5ra polypeptider\/affibodies.<\/li>\n<li>St\u00e4rkt samarbete mellan akademiska och industriella partners \u00f6ver hela Europa, vilket banar v\u00e4g f\u00f6r framtida projekt.<\/li>\n<li>Som en intressant extra uppt\u00e4ckt kunde projektet visa terapeutisk potential f\u00f6r autoimmuna tillst\u00e5nd.<\/li>\n<\/ul>\n<p><strong>N\u00e4sta steg:<\/strong><br \/>\nBaserat p\u00e5 dessa resultat \u00e4r n\u00e4sta steg att fokusera p\u00e5 slutliga prekliniska studier och utforska potentiella kommersialiseringsstrategier f\u00f6r att p\u00e5skynda klinisk till\u00e4mpning.<\/p>\n","protected":false},"featured_media":0,"template":"","meta":{"_acf_changed":false},"news_categories":[321],"protected-content":[],"class_list":["post-7312","news","type-news","status-publish","hentry","news_categories-science"],"acf":[],"_links":{"self":[{"href":"https:\/\/oncopeptides.com.haus.se\/sv\/wp-json\/wp\/v2\/news\/7312","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/oncopeptides.com.haus.se\/sv\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/oncopeptides.com.haus.se\/sv\/wp-json\/wp\/v2\/types\/news"}],"wp:attachment":[{"href":"https:\/\/oncopeptides.com.haus.se\/sv\/wp-json\/wp\/v2\/media?parent=7312"}],"wp:term":[{"taxonomy":"news_categories","embeddable":true,"href":"https:\/\/oncopeptides.com.haus.se\/sv\/wp-json\/wp\/v2\/news_categories?post=7312"},{"taxonomy":"protected-content","embeddable":true,"href":"https:\/\/oncopeptides.com.haus.se\/sv\/wp-json\/wp\/v2\/protected-content?post=7312"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}